Scientists are warning a new stem cell law in Britain will hamper research aimed at treatments for diseases like Alzheimer's and diabetes.
A group of 29 scientists, including three Nobel laureates, sent a letter to the government protesting a donor consent requirement for the use of cloned embryonic stem cells, The Daily Telegraph reported Monday.
The scientists say the requirement set out by the Human Fertilization and Embryology Bill moving through Parliament would deny them access to tissue banks. The banks serve as libraries of genes that trigger the serious diseases scientists want to study.
Much of the tissue currently stored in the banks was collected before it became possible to clone embryos so the patients would not have been able to give their consent.
"For scientists to clone human embryos without the consent of the cell donors, which contains the genetic materials, would be completely unethical," says Dr. Calum MacKellar of the Scottish Council on Human Bioethics.
Copyright 2008 by United Press International
Related stories:
Genetic research using human samples requires new types of informed consent
Genetic studies involving the long term storage and study of human samples hold great promise for medical research—but they also pose new threats to individuals such as uninsurability, unemployability, and discrimination, say a team of researchers in this week's
PLoS Medicine.
Landmark study reports breakdown in biotech patent system
The world's intellectual property system is broken. It's stopping lifesaving technologies from reaching the people who need them most in developed and developing countries, according to the authors of a report released in Ottawa today by an international coalition of experts.
Updated guidelines for stem cell research released
The National Academies today released amended guidelines for research involving human embryonic stem cells, revising those that were issued in 2005 and updated in 2007. The Academies originally produced the guidelines to offer a common set of ethical standards for the responsible conduct of research using human stem cells, an area that, due to an absence of comprehensive federal funding, was lacking national standards. Since their initial release, the guidelines have served effectively as the basis for oversight of this research in the United States. In addition, a standing advisory committee -- a joint project between the Academies' National Research Council and Institute of Medicine -- was established to monitor and review scientific advances and determine any need for revisions.
Oil and gas projects in western Amazon threaten biodiversity and indigenous peoples
The western Amazon, home to the most biodiverse and intact rainforest left on Earth, may soon be covered with oil rigs and pipelines.
Managing incidental findings in human subjects research
Article offers first major consensus recommendations for IFs
An incidental finding (IF) is a finding concerning an individual research participant that has potential health or reproductive importance, is discovered in the course of conducting research, but is beyond the aims of the study. IFs are an increasingly common byproduct of research using powerful technologies that generate "extra" data. Because IFs can potentially save lives but also cause alarm, the decision on whether or not to disclose them to research participants has been a major dilemma. Little guidance currently exists on how to approach this problem. A two-year project supported by the National Human Genome Research Institute at NIH has now published the first major recommendations for how to anticipate and manage IFs in genetic, genomic, and imaging research, suggesting broader application to other research domains. This project, led by Prof. Susan Wolf at the University of Minnesota's Consortium on Law and Values in Health, Environment & the Life Sciences, involved a multidisciplinary group of leading experts from the U.S. and Canada. The project has published a 17-article symposium including the consensus paper, which appears in the Summer '08 issue of the
Journal of Law, Medicine & Ethics.
Intimate examinations should not be performed without consent
Editorial: Informed consent and intimate examinations
Intimate examinations, performed by medical students on anaesthetised patients, are often carried out without adequate consent from patients, but this violates their basic human rights and should not be allowed, claims an editorial in the July issue of
Student BMJ.
3 sequencing companies join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences, a Roche company, Branford, Conn.; Applied Biosystems, an Applera Corp. business, Foster City, Calif.; and Illumina Inc., San Diego.
Ethical implications of modifying lethal injection protocols
A team of medical, ethical, and legal scholars argues in this week's
PLoS Medicine that in some US states the modification of lethal injection protocols is tantamount to experimentation upon prisoners without the prisoners' consent and without any ethical safeguards.